{"id":"https://openalex.org/W2593772017","doi":null,"title":"Development and validation of a stability-indicating RP-HPLC method for the simultaneous quantification of Olmesartan Medoxomil and Chlorthalidone insolid dosage form","display_name":"Development and validation of a stability-indicating RP-HPLC method for the simultaneous quantification of Olmesartan Medoxomil and Chlorthalidone insolid dosage form","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2593772017","mag":"2593772017"},"language":"en","primary_location":{"id":"mag:2593772017","doi":null,"is_oa":false,"landing_page_url":"https://www.scholarsresearchlibrary.com/articles/development-and-validation-of-a-stabilityindicating-rphplc-method-for-the-simultaneous-quantification-of-olmesartan-medo.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306507771","display_name":"Der pharmacia lettre","issn_l":"0975-5071","issn":["0975-5071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Der pharmacia lettre","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Pratap Murali","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pratap Murali","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052776326","display_name":"P. Sunil Kumar Chaitanya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Sunil Kumar Chaitanya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113307483","display_name":"Ch Pavani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ch Pavani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067438879","display_name":"G. Rohini Reddy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Rohini Reddy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5010962668","display_name":"Rajesh Kumar Ramalingam","orcid":"https://orcid.org/0000-0003-0690-1283","observed_orcids":["https://orcid.org/0000-0003-0690-1283"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajesh Kumar Ramalingam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0690-1283","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"6","first_page":"148","last_page":"157"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11709","display_name":"Traditional Chinese Medicine Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olmesartan-medoxomil","display_name":"olmesartan medoxomil","score":0.925000011920929},{"id":"https://openalex.org/keywords/chlorthalidone","display_name":"chlorthalidone","score":1.0},{"id":"https://openalex.org/keywords/simultaneous-determination","display_name":"simultaneous determination","score":0.781000018119812},{"id":"https://openalex.org/keywords/stability-indicating-method","display_name":"stability-indicating assay","score":0.8700000047683716},{"id":"https://openalex.org/keywords/rp-hplc-method-development","display_name":"RP-HPLC method development","score":0.7310000061988831},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.7360000014305115},{"id":"https://openalex.org/keywords/fixed-dose-combination-tablets","display_name":"fixed-dose combination tablets","score":0.7889999747276306},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.9800000190734863},{"id":"https://openalex.org/keywords/drug-quantification","display_name":"pharmaceutical analysis","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C2779766728","wikidata":"https://www.wikidata.org/wiki/Q421156","display_name":"Olmesartan","level":3,"score":0.9509033560752869},{"id":"https://openalex.org/C2780427769","wikidata":"https://www.wikidata.org/wiki/Q425289","display_name":"Chlorthalidone","level":3,"score":0.9328650236129761},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6777317523956299},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6289526224136353},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.4192807972431183},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3158641457557678},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.14389654994010925},{"id":"https://openalex.org/C2779918671","wikidata":"https://www.wikidata.org/wiki/Q200656","display_name":"Diuretic","level":2,"score":0.08998259902000427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06692913174629211},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2593772017","doi":null,"is_oa":false,"landing_page_url":"https://www.scholarsresearchlibrary.com/articles/development-and-validation-of-a-stabilityindicating-rphplc-method-for-the-simultaneous-quantification-of-olmesartan-medo.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306507771","display_name":"Der pharmacia lettre","issn_l":"0975-5071","issn":["0975-5071"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Der pharmacia lettre","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7108326708","https://openalex.org/W915619764","https://openalex.org/W2010980936","https://openalex.org/W2097377269","https://openalex.org/W4205545612","https://openalex.org/W7219542267","https://openalex.org/W3114959840","https://openalex.org/W4390007685","https://openalex.org/W2054502363","https://openalex.org/W2184627506"],"abstract_inverted_index":{"A":[0],"simple,":[1],"rapid,":[2,217],"accurate,":[3,203],"precise":[4],"and":[5,26,73,85,92,119,126,135,145,154,159,171,179,187,205,218,220],"economical":[6],"reverse":[7],"phase":[8,53,210],"high":[9],"performance":[10],"liquid":[11],"chromatographic":[12],"method":[13,98,109,200,214],"was":[14,34,70,75,89,99,110,156],"developed":[15],"for":[16,86,123,184,226],"simultaneous":[17,227],"quantification":[18],"of":[19,30,54,83,107,115,132,148,151,165,229],"two":[20],"anti-hypertensive":[21],"drugs,":[22],"viz.,":[23],"Olmesartan":[24,87,124,133,152,169],"medoxomil":[25,88,125],"Chlorthalidone.":[27],"The":[28,67,80,96,105,129,162,207],"separation":[29],"both":[31,166,230],"the":[32,108,167,174,192,199],"drugs":[33,168,231],"achieved":[35],"on":[36],"ODS":[37],"C":[38],"18":[39],"column":[40],"(250":[41],"\u00d7":[42],"4.6":[43],"mm":[44],"id,":[45],"5":[46],"\u03bcm":[47],"particle":[48],"size)":[49],"using":[50],"a":[51,113],"mobile":[52,209],"Potassium":[55],"dihydrogen":[56],"ortho":[57],"phosphate":[58],"buffer":[59],"solution":[60],"(at":[61],"pH":[62],"4):":[63],"Acetonitrile":[64],"(25:75":[65],"v/v).":[66],"flow":[68],"rate":[69],"1.2":[71],"ml/min":[72],"detection":[74],"done":[76],"at":[77,112],"240":[78],"nm.":[79],"retention":[81],"time":[82],"Chlorthalidone":[84,127,136,155,172],"2.3":[90],"mins":[91,94],"3.7":[93],"respectively.":[95,128,161,181],"proposed":[97],"validated":[100],"as":[101],"per":[102],"ICH":[103],"guidelines.":[104],"linearity":[106],"evaluated":[111],"range":[114],"50":[116],"to":[117,121],"300\u03bcg/ml":[118],"31.25":[120],"187.5\u03bcg/ml":[122],"Correlation":[130],"Coefficient":[131],"Medoxomil":[134,153,170],"were":[137,142,177,189],"0.999":[138],"each.":[139],"Precision":[140],"studies":[141],"carried":[143],"out":[144],"%":[146],"RSD":[147],"peak":[149],"areas":[150],"about":[157],"0.69":[158],"0.64":[160],"percentage":[163],"recoveries":[164],"from":[173],"tablet":[175],"formulation":[176],"100.12%":[178],"100.10%":[180],"Results":[182],"obtained":[183],"LOQ,":[185],"LOD":[186],"Robustness":[188],"well":[190],"within":[191],"acceptance":[193],"criteria.":[194],"Validation":[195],"results":[196],"indicated":[197],"that":[198],"is":[201],"linear,":[202],"precise,":[204],"robust.":[206],"simple":[208],"composition":[211],"makes":[212],"this":[213],"cost":[215],"effective,":[216],"non-tedious":[219],"can":[221],"also":[222],"be":[223],"successfully":[224],"employed":[225],"estimation":[228],"in":[232],"commercial":[233],"products.":[234]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-03-16T00:00:00"}